# Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

> **NCT00139685** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 350 (—)

## Conditions studied

- Contraception
- Bone Density

## Interventions

- **DRUG:** Depo-Provera Contraceptive Injection - DP150CI

## Key facts

- **NCT ID:** NCT00139685
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2006-08
- **Final completion:** 2007-07
- **Target enrollment:** 350 (—)
- **Last updated:** 2008-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139685, "Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00139685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*